112 related articles for article (PubMed ID: 10529597)
1. IL-4 induces eotaxin in human dermal fibroblasts.
Mochizuki M; Schröder J; Christophers E; Yamamoto S
Int Arch Allergy Immunol; 1999; 120 Suppl 1():19-23. PubMed ID: 10529597
[TBL] [Abstract][Full Text] [Related]
2. IL-4 induces eotaxin: a possible mechanism of selective eosinophil recruitment in helminth infection and atopy.
Mochizuki M; Bartels J; Mallet AI; Christophers E; Schröder JM
J Immunol; 1998 Jan; 160(1):60-8. PubMed ID: 9551956
[TBL] [Abstract][Full Text] [Related]
3. Th1- and Th2-type cytokines regulate the expression and production of eotaxin and RANTES by human lung fibroblasts.
Teran LM; Mochizuki M; Bartels J; Valencia EL; Nakajima T; Hirai K; Schröder JM
Am J Respir Cell Mol Biol; 1999 Apr; 20(4):777-86. PubMed ID: 10101011
[TBL] [Abstract][Full Text] [Related]
4. Delayed production of biologically active O-glycosylated forms of human eotaxin by tumor-necrosis-factor-alpha-stimulated dermal fibroblasts.
Noso N; Bartels J; Mallet AI; Mochizuki M; Christophers E; Schröder JM
Eur J Biochem; 1998 Apr; 253(1):114-22. PubMed ID: 9578468
[TBL] [Abstract][Full Text] [Related]
5. Activation of eotaxin-3/CCLl26 gene expression in human dermal fibroblasts is mediated by STAT6.
Hoeck J; Woisetschläger M
J Immunol; 2001 Sep; 167(6):3216-22. PubMed ID: 11544308
[TBL] [Abstract][Full Text] [Related]
6. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-alpha-induced fibroblasts.
Hoeck J; Woisetschläger M
J Immunol; 2001 Apr; 166(7):4507-15. PubMed ID: 11254707
[TBL] [Abstract][Full Text] [Related]
7. Dermal fibroblasts represent a potent major source of human eotaxin: In vitro production and cytokine-mediated regulation.
Miyamasu M; Nakajima T; Misaki Y; Izumi S; Tsuno N; Kasahara T; Yamamoto K; Morita Y; Hirai K
Cytokine; 1999 Oct; 11(10):751-8. PubMed ID: 10525313
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-13 and tumour necrosis factor-alpha synergistically induce eotaxin production in human nasal fibroblasts.
Terada N; Hamano N; Nomura T; Numata T; Hirai K; Nakajima T; Yamada H; Yoshie O; Ikeda-Ito T; Konno A
Clin Exp Allergy; 2000 Mar; 30(3):348-55. PubMed ID: 10691892
[TBL] [Abstract][Full Text] [Related]
9. Detection of mRNA for eotaxin-2 and eotaxin-3 in human dermal fibroblasts and their distinct activation profile on human eosinophils.
Dulkys Y; Schramm G; Kimmig D; Knöss S; Weyergraf A; Kapp A; Elsner J
J Invest Dermatol; 2001 Apr; 116(4):498-505. PubMed ID: 11286614
[TBL] [Abstract][Full Text] [Related]
10. Synergistic induction of eotaxin expression in human keratocytes by TNF-alpha and IL-4 or IL-13.
Kumagai N; Fukuda K; Ishimura Y; Nishida T
Invest Ophthalmol Vis Sci; 2000 May; 41(6):1448-53. PubMed ID: 10798661
[TBL] [Abstract][Full Text] [Related]
11. Effects of Th2 cytokines on chemokine expression in the lung: IL-13 potently induces eotaxin expression by airway epithelial cells.
Li L; Xia Y; Nguyen A; Lai YH; Feng L; Mosmann TR; Lo D
J Immunol; 1999 Mar; 162(5):2477-87. PubMed ID: 10072486
[TBL] [Abstract][Full Text] [Related]
12. Regulation of human eotaxin generation by Th1-/Th2-derived cytokines.
Miyamasu M; Misaki Y; Yamaguchi M; Yamamoto K; Morita Y; Matsushima K; Nakajima T; Hirai K
Int Arch Allergy Immunol; 2000 May; 122 Suppl 1():54-8. PubMed ID: 10867510
[TBL] [Abstract][Full Text] [Related]
13. Human eotaxin induces alpha 4 and beta 2 integrin-dependent eosinophil accumulation in rat skin in vivo: delayed generation of eotaxin in response to IL-4.
Sanz MJ; Ponath PD; Mackay CR; Newman W; Miyasaka M; Tamatani T; Flanagan BF; Lobb RR; Williams TJ; Nourshargh S; Jose PJ
J Immunol; 1998 Apr; 160(7):3569-76. PubMed ID: 9531320
[TBL] [Abstract][Full Text] [Related]
14. Regulatory mechanisms of galectin-9 and eotaxin-3 synthesis in epidermal keratinocytes: possible involvement of galectin-9 in dermal eosinophilia of Th1-polarized skin inflammation.
Igawa K; Satoh T; Hirashima M; Yokozeki H
Allergy; 2006 Dec; 61(12):1385-91. PubMed ID: 17073866
[TBL] [Abstract][Full Text] [Related]
15. Inflammatory cytokines modulate eotaxin release by human lung fibroblast cell line.
Sato E; Nelson DK; Koyama S; Hoyt JC; Robbins RA
Exp Lung Res; 2001 Mar; 27(2):173-83. PubMed ID: 11258804
[TBL] [Abstract][Full Text] [Related]
16. IL-17E upregulates the expression of proinflammatory cytokines in lung fibroblasts.
Létuvé S; Lajoie-Kadoch S; Audusseau S; Rothenberg ME; Fiset PO; Ludwig MS; Hamid Q
J Allergy Clin Immunol; 2006 Mar; 117(3):590-6. PubMed ID: 16522458
[TBL] [Abstract][Full Text] [Related]
17. Differential regulation of epithelial-derived C-C chemokine expression by IL-4 and the glucocorticoid budesonide.
Stellato C; Matsukura S; Fal A; White J; Beck LA; Proud D; Schleimer RP
J Immunol; 1999 Nov; 163(10):5624-32. PubMed ID: 10553092
[TBL] [Abstract][Full Text] [Related]
18. Identification of an N-terminally truncated form of the chemokine RANTES and granulocyte-macrophage colony-stimulating factor as major eosinophil attractants released by cytokine-stimulated dermal fibroblasts.
Noso N; Sticherling M; Bartels J; Mallet AI; Christophers E; Schröder JM
J Immunol; 1996 Mar; 156(5):1946-53. PubMed ID: 8596049
[TBL] [Abstract][Full Text] [Related]
19. Increase effect of transforming growth factor on eotaxin production by normal cultured dermal fibroblasts stimulated with interleukin-4: inhibitory effect of suplatast tosilate on eotaxin production.
Bae SJ; Lee JB; Shimizu K; Kuwazuka Y
Immunol Invest; 2010 Jan; 39(2):93-102. PubMed ID: 20136617
[TBL] [Abstract][Full Text] [Related]
20. Induction of eotaxin production by interleukin-4, interleukin-13 and lipopolysaccharide by nasal fibroblasts.
Nonaka M; Pawankar R; Fukumoto A; Ogihara N; Sakanushi A; Yagi T
Clin Exp Allergy; 2004 May; 34(5):804-11. PubMed ID: 15144475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
